106 related articles for article (PubMed ID: 7616442)
1. Interaction of Ro 40-5967 and verapamil with the stably expressed alpha 1-subunit of the cardiac L-type calcium channel.
Lacinová L; Welling A; Bosse E; Ruth P; Flockerzi V; Hofmann F
J Pharmacol Exp Ther; 1995 Jul; 274(1):54-63. PubMed ID: 7616442
[TBL] [Abstract][Full Text] [Related]
2. The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels.
Mehrke G; Zong XG; Flockerzi V; Hofmann F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1483-8. PubMed ID: 7996461
[TBL] [Abstract][Full Text] [Related]
3. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
Bezprozvanny I; Tsien RW
Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
[TBL] [Abstract][Full Text] [Related]
4. Expression of the L-type calcium channel with two different beta subunits and its modulation by Ro 40-5967.
Welling A; Lacinova L; Donatin K; Ludwig A; Bosse E; Flockerzi V; Hofmann F
Pflugers Arch; 1995 Jan; 429(3):400-11. PubMed ID: 7761264
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of voltage- and use-dependent block of class A Ca2+ channels by mibefradil.
Aczél S; Kurka B; Hering S
Br J Pharmacol; 1998 Oct; 125(3):447-54. PubMed ID: 9806326
[TBL] [Abstract][Full Text] [Related]
6. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
Sarsero D; Fujiwara T; Molenaar P; Angus JA
Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
[TBL] [Abstract][Full Text] [Related]
7. Resting state block and use independence of rat vascular muscle Ca++ channels by Ro 40-5967.
Mishra SK; Hermsmeyer K
J Pharmacol Exp Ther; 1994 Apr; 269(1):178-83. PubMed ID: 8169822
[TBL] [Abstract][Full Text] [Related]
8. HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers.
Chouabe C; Drici MD; Romey G; Barhanin J; Lazdunski M
Mol Pharmacol; 1998 Oct; 54(4):695-703. PubMed ID: 9765513
[TBL] [Abstract][Full Text] [Related]
9. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines.
Schuster A; Lacinová L; Klugbauer N; Ito H; Birnbaumer L; Hofmann F
EMBO J; 1996 May; 15(10):2365-70. PubMed ID: 8665843
[TBL] [Abstract][Full Text] [Related]
10. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
Gomora JC; Xu L; Enyeart JA; Enyeart JJ
J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
[TBL] [Abstract][Full Text] [Related]
11. The block of the expressed L-type calcium channel is modulated by the beta 3 subunit.
Lacinová L; Ludwig A; Bosse E; Flockerzi V; Hofmann F
FEBS Lett; 1995 Oct; 373(2):103-7. PubMed ID: 7589444
[TBL] [Abstract][Full Text] [Related]
12. The action of calcium channel blockers on recombinant L-type calcium channel alpha1-subunits.
Morel N; Buryi V; Feron O; Gomez JP; Christen MO; Godfraind T
Br J Pharmacol; 1998 Nov; 125(5):1005-12. PubMed ID: 9846638
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells.
Nilius B; Prenen J; Kamouchi M; Viana F; Voets T; Droogmans G
Br J Pharmacol; 1997 Jun; 121(3):547-55. PubMed ID: 9179399
[TBL] [Abstract][Full Text] [Related]
14. Potential-dependent inhibition of cardiac Ca2+ inward currents by Ro 40-5967 and verapamil: relation to negative inotropy.
Fang LM; Osterrieder W
Eur J Pharmacol; 1991 Apr; 196(2):205-7. PubMed ID: 1651875
[TBL] [Abstract][Full Text] [Related]
15. Ca2+ channel actions of the non-dihydropyridine Ca2+ channel antagonist Ro 40-5967 in vascular muscle cells cultured from dog coronary and saphenous arteries.
Bian K; Hermsmeyer K
Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):191-6. PubMed ID: 7694155
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and Gbetagamma modulation of Ca(v)2.2 channels with different auxiliary beta subunits.
Meir A; Dolphin AC
Pflugers Arch; 2002 May; 444(1-2):263-75. PubMed ID: 11976940
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of the T-type Ca2+ current of mouse spermatogenic cells.
Arnoult C; Villaz M; Florman HM
Mol Pharmacol; 1998 Jun; 53(6):1104-11. PubMed ID: 9614215
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells.
Rossier MF; Ertel EA; Vallotton MB; Capponi AM
J Pharmacol Exp Ther; 1998 Dec; 287(3):824-31. PubMed ID: 9864260
[TBL] [Abstract][Full Text] [Related]
19. State-dependent verapamil block of the cloned human Ca(v)3.1 T-type Ca(2+) channel.
Freeze BS; McNulty MM; Hanck DA
Mol Pharmacol; 2006 Aug; 70(2):718-26. PubMed ID: 16699084
[TBL] [Abstract][Full Text] [Related]
20. In vitro pharmacologic profile of Ro 40-5967, a novel Ca2+ channel blocker with potent vasodilator but weak inotropic action.
Osterrieder W; Holck M
J Cardiovasc Pharmacol; 1989 May; 13(5):754-9. PubMed ID: 2472524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
